Vol 7, No 2 (2021)
Research paper
Published online: 2021-06-30

open access

Page views 1167
Article views/downloads 55
Get Citation

Connect on Social Media

Connect on Social Media

Sodium hypochlorite baths in atopic dermatitis and their influence on the skin microbiome

Klaudia Tutka1, Adam Reich1
Forum Dermatologicum 2021;7(2):43-49.

Abstract

Introduction: Atopic dermatitis (AD) is a disease of multifactorial ethology. However, the bacterial microflora of the skin, especially Staphylococcus aureus, plays an important role in its the pathogenesis. Continuously, new therapies are sought which will block factors exacerbating the disease and significantly support the AD treatment. The aim of the study was to determine the effect of sodium hypochlorite baths on the eradication of St. aureus from the skin and to assess their effect on AD severity.

Material and methods: The study was conducted among 54 patients suffering from AD. A half of the patients were randomly assigned to the group treated with sodium hypochlorite baths (study group) in addition to the standard therapy of AD, the remaining patients were treated with conventional treatment (control group). The severity of the disease and the intensity of the itch were assessed in each patient at the time of enrollment into the study and 6 weeks later. A skin smear was taken for microbiological examination with pathogen identification and semi-quantitative evaluation of the isolated bacteria strains.

Results: Patients using baths in diluted sodium hypochlorite showed a greater improvement of AD severity compared to those using conventional treatment only (relative EASI improvement: 42.0% ± 32.9% vs. –33.1% ± 88.6%, p < 0.01; relative SCORAD improvement: 33.5 ± 25.9% vs. –6.7 ± 36.8%, p < 0.001). Additionally, a greater reduction of itch was observed in the study group compared to the control group (ΔNRS: 1.8 ± 2.2 vs. 0.7 ± 2.2, p = 0.04) as well as significant improvement of quality of life was noted (study group: mean DLQI before treatment: 12.7 ± 6.7 points, mean DLQI after treatment: 7.3 ± 5.4, p < 0.001; control group: mean DLQI before treatment: 10.8 ± 7.5 points, mean DLQI after treatment: 8.7 ± 5.6, p < 0.82). However, the relationship between the applied therapy and the eradication of St. aureus has not been confirmed.

Conclusions: Bathing in diluted sodium hypochlorite allowed to reduce the intensity of AD and to improve the quality of life, while ensuring good tolerability and safety of the therapy. However, no significant effect of the therapy was observed on the reduction of the number of St. aureus colonies on the skin.

Article available in PDF format

View PDF (Polish) Download PDF file

References

  1. Feizy V, Ghobadi A. Atopic dermatitis and systemic autoimmune diseases: a descriptive cross sectional study. Dermatol Online J. 2006; 12(3): 3.
  2. Nakatsuji T, Gallo RL. The role of the skin microbiome in atopic dermatitis. Ann Allergy Asthma Immunol. 2019; 122(3): 263–269.
  3. Rangel SM, Paller AS. Bacterial colonization, overgrowth, and superinfection in atopic dermatitis. Clin Dermatol. 2018; 36(5): 641–647.
  4. Williams RE, Gibson AG, Aitchison TC, et al. Assessment of a contact-plate sampling technique and subsequent quantitative bacterial studies in atopic dermatitis. Br J Dermatol. 1990; 123(4): 493–501.
  5. Totté JEE, van der Feltz WT, Hennekam M, et al. Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis. Br J Dermatol. 2016; 175(4): 687–695.
  6. Boguniewicz M, Leung DYM. Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol. 2010; 125(1): 4–13; quiz 14.
  7. Bożek A, Reich A. Metody oceny nasilenia atopowego zapalenia skóry. Przegl Dermatol. 2016; 103: 479–485.
  8. Chopra R, Vakharia PP, Sacotte R, et al. Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis. Br J Dermatol. 2017; 177(5): 1316–1321.
  9. Reich A, Chatzigeorkidis E, Zeidler C, et al. Tailoring the Cut-off Values of the Visual Analogue Scale and Numeric Rating Scale in Itch Assessment. Acta Derm Venereol. 2017; 97(6): 759–760.
  10. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994; 19(3): 210–216.
  11. Barnes TM, Greive KA. Use of bleach baths for the treatment of infected atopic eczema. Australas J Dermatol. 2013; 54(4): 251–258.
  12. Bohaty BR, Durham KC, Abramovici G, et al. A novel new sodium hypochlorite formulated wash as an adjunctive approach to the management of pediatric subjects with moderate to severe atopic dermatitis colonised with Staphylococcus aureus. J Am Acad Dermatol. 2014; 70(Suppl. 1): AB60 (Abstract).
  13. Coetzee E, Whitelaw A, Kahn D, et al. The use of topical, un-buffered sodium hypochlorite in the management of burn wound infection. Burns. 2012; 38: 529–533.
  14. Fader RC, Maurer A, Stein MD, et al. Sodium hypochlorite decontamination of split-thickness cadaveric skin infected with bacteria and yeast with subsequent isolation and growth of basal cells to confluency in tissue culture. Antimicrob Agents Chemother. 1983; 24: 181–185.
  15. Huang JT, Abrams M, Tlougan B, et al. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics. 2009; 123(5): e808–e814.
  16. Sassone LM, Fidel RA, Murad CF, et al. Antimicrobial activity of sodium hypochlorite and chlorhexidine by two different tests. Aust Endod J. 2008; 34(1): 19–24.
  17. Williams MR, Gallo RL. Evidence that Human Skin Microbiome Dysbiosis Promotes Atopic Dermatitis. J Invest Dermatol. 2017; 137(12): 2460–2461.
  18. Leung TH, Zhang LF, Wang J, et al. Topical hypochlorite ameliorates NF-kappa B-mediated skin diseases in mice. J Clin Invest. 2013; 123: 5361–5370.